A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution

Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
10/1998
10/28/1998	EP0874058A1 Procedure for obtaining a thermoresistant biological extract
10/28/1998	EP0874054A2 Vector for the expression of immunoglobulin-cytokine fusionproteins in malignant B Cells
10/28/1998	EP0873332A1 Discodermolide compounds and pharmaceutical compositions containing them for cancer therapy
10/28/1998	EP0873049A1 Methods for enhanced virus-mediated dna transfer using molecules with virus- and cell-binding domains
10/28/1998	EP0708674A4 Blood collection system
10/28/1998	EP0677044B1 (in vivo) method of obtaining cell components
10/28/1998	CN1197393A Tumor rejection antigens presented by HLA-B44 molecules, and uses thereof
10/28/1998	CN1197392A Prepn. of pharmaceutical grade hemoglobins by heat treatment in partially oxygenated form
10/28/1998	CN1196956A Influenza vaccine
10/28/1998	CN1196951A Health wine for nourishing marrow and benefitting semen
10/28/1998	CN1196942A Compound Chinese and western medicinal compsn. for treating 'down elimination' diabetes
10/28/1998	CN1196936A Medicament for treating primary glomerular disease and its prepn. method
10/28/1998	CN1040395C External-use medicine with skin care and beautifying function
10/27/1998	US5827897 Insulin-resistance in a mammal treated by administering a synergistic mixture of a retinoid and a fatty acid; antidiabetic agents
10/27/1998	US5827853 Mixture containing product from fermentation by streptomyces for topical application to skin or hair, to improve texture, surface smoothness, firmness
10/27/1998	US5827829 Use of a hymenoptera venom for the manufacture of a medicament for treating DNA virus infections
10/27/1998	US5827741 Cryopreservation of human adult and fetal pancreatic cells and human platelets
10/27/1998	US5827740 A mixture of glucocorticoids and an adenosine monophosphates inducing the fat cells by cell differentiation
10/27/1998	US5827737 Stable drosophila cell line
10/27/1998	US5827736 Hybridomas having both immunoprotective and secretory activity, viability and functionality after transplanting, islet or chromaffin cells, for treatment of diabetes or parkinson's disease
10/27/1998	US5827708 Nucleotide sequence which codes for the polypeptide expressed by transfer ribonucleic acid synthetase gene; screening for antibacterial compounds; from genetically enginered cells
10/27/1998	US5827707 Method for manufacturing minimal volume capsules containing biological materials
10/27/1998	US5827702 Contacting an ocular cell with exogenous nucleic acid under conditions permissive for it uptake and expression; genetic engineering
10/27/1998	US5827692 Parasiticides against heartworm, elephantiasis
10/27/1998	US5827671 Antibodies raised against proteins of Leishmania which are expressed at an increased level in the amastigote form
10/27/1998	US5827643 Method of increasing viability of stored erythrocytes by addition of lipoic, dihydrolipoic, 6,8-bisnortetralipoic, or tetranorlipoic acid
10/27/1998	US5827642 Adding lymphocyte population to culture medium in vitro, adding non-dividing peripheral blood mononuclear cells as feeder cells, adding non-dividing lymphoblastoid cells, adding monoclonal antibody, incubating culture
10/27/1998	US5827641 Inner endothelial cell layer, middle stromal cell-collagen mixture layer and external epithelial cell layer
10/27/1998	CA2063721C Mycobacterium chelonae polar glycopeptidolipids-based immune booster medication
10/27/1998	CA2057463C Vitamin/mineral composition
10/27/1998	CA1340102C Novel polypeptides with a blood coagulation-inhibiting action, processesfor their preparation and isolation, their use and agents containing them
10/22/1998	WO1998046785A1 Dendritic cell hybrids
10/22/1998	WO1998046781A2 Novel transgene expression system for increased persistence
10/22/1998	WO1998046780A1 Novel adenoviral vectors capable of facilitating increased persistence of transgene expression
10/22/1998	WO1998046779A1 Adenoviral vectors comprising a modified e4 region but retaining e4orf3
10/22/1998	WO1998046760A1 A gene delivery vehicle expressing the apoptosis-inducing proteins vp2 and/or apoptin
10/22/1998	WO1998046750A1 flt3 LIGAND CHIMERIC PROTEINS
10/22/1998	WO1998046624A1 A method for stimulating red blood cell production
10/22/1998	WO1998046325A1 Microfabricated filter and capsule formed by substrates
10/22/1998	WO1998046264A1 Antagonistic anti-avb3 integrin antibodies
10/22/1998	WO1998046261A1 Vaginal lactobacillus medicant
10/22/1998	WO1998046245A1 Method and composition for treating sleep apnea
10/22/1998	WO1998046082A1 Cell-coated supports
10/22/1998	WO1998035028A3 An oncolytic/immunogenic complementary-adenoviral vector system
10/22/1998	WO1998022158A3 Graft prosthesis, materials and methods
10/22/1998	DE19745792C1 Isolation of wound healing regulatory factors
10/22/1998	DE19716098A1 Fibroblasten mit einem Fremdgen enthaltende Zusammensetzung zur Behandlung von Wunden Fibroblasts with a foreign gene containing composition for the treatment of wounds
10/22/1998	CA2287472A1 Novel adenoviral vectors capable of facilitating increased persistence of transgene expression
10/22/1998	CA2287076A1 Novel transgene expression system for increased persistence
10/22/1998	CA2286580A1 Adenoviral vectors comprising a modified e4 region but retaining e4orf3
10/22/1998	CA2284726A1 Antagonistic anti-avb3 integrin antibodies
10/22/1998	CA2284127A1 Flt3 ligand chimeric proteins
10/21/1998	EP0872249A1 Gene transfer preparation
10/21/1998	EP0872231A1 Pharmaceutical compositions comprising lactobacilli suitable for trans-mucosal administration
10/21/1998	EP0871756A2 High efficiency ex vivo transduction of cells by high titer recombinant retroviral preparations
10/21/1998	EP0871748A2 Delivery of biologically active polypeptides
10/21/1998	EP0871742A2 Vectors and viruses for use in gene therapy
10/21/1998	EP0871738A1 Viral recombinant pseudo-particles and vaccinal and anti-tumoral applications
10/21/1998	EP0871726A1 Multispecific chimeric receptors
10/21/1998	EP0871713A2 The use of lecithin-cholesterol acyltransferase (lcat) in the treatment of atherosclerosis
10/21/1998	EP0871706A1 Stabilization of blood platelets against low temperature activation
10/21/1998	EP0871495A1 Redirection of cellular immunity by receptor chimeras
10/21/1998	EP0871487A1 Dendritic cell stimulatory factor
10/21/1998	EP0871483A1 Helper virus-free aav production
10/21/1998	EP0871476A1 Dried blood factor composition comprising trehalose
10/21/1998	EP0871458A1 Method of decreasing radiation or radio-mimetic chemotherapy for hematopoietic pluripotent cell engraftment
10/21/1998	EP0871457A1 Isolated stromal cells and methods of using the same
10/21/1998	EP0871455A1 In vitro growth of functional islets of langerhans and in vivo uses thereof
10/21/1998	EP0871363A1 Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria
10/21/1998	EP0738327B1 Host-vector system for use in gene therapy
10/21/1998	CN1196264A Strong waist and anti-protrusion pill
10/21/1998	CN1196263A Traditional Chinese medicine preparation for treating leukocythemia
10/21/1998	CN1196258A Compounding method and technology for pure natural anti-senile preparation
10/21/1998	CN1196251A Medicinal liquor for treating rheumatoid disease and preparation technology thereof
10/21/1998	CN1196243A Powder agent formula for treating acne and seborrhea and preparation method
10/21/1998	CN1196242A Four-in-one ointment for gynaecology external use
10/21/1998	CN1196240A Heme antianemia medicine and preparation method
10/21/1998	CN1196198A Earthworm lactate nutrient solution and preparation method thereof
10/20/1998	US5824839 Delivery of gene products via mesangial cells
10/20/1998	US5824776 Cell-targeted lytic pore-forming agents
10/20/1998	US5824655 Anti-transforming growth factor-β gene therapy
10/20/1998	US5824640 Substances of polypeptide nature useful in human therapy
10/20/1998	US5824549 Transformed human T cell
10/20/1998	US5824548 Method of increasing survival of cultured primate embryos in medium containing exogenous gonadotrophin releasor hormone
10/20/1998	US5824544 Adenovirus vectors for gene therapy
10/20/1998	US5824505 Vectors, transformed cells and process for the preparation of hirudin
10/20/1998	US5824331 Bioartificial devices and cellular matrices therefor
10/20/1998	US5824318 Avirulent herpetic viruses useful as tumoricidal agents and vaccines
10/20/1998	US5824306 Dirofilaria and brugia ankyrin proteins, nucleic acid molecules, and uses thereof
10/20/1998	US5824304 Peripheralization of hematopoietic stem cells
10/20/1998	US5824299 Administering an ip-10 polypeptide to decrease non-neoplastic endothelial cell proliferation; treating hemangioma, keloids, proliferative retinal disorder, inflammation, fibrosis
10/20/1998	US5824216 Blood collection container
10/15/1998	WO1998045712A2 20 human secreted proteins
10/15/1998	WO1998045443A1 Radioisotope concentrator methods and compositions
10/15/1998	WO1998045407A1 Magnetic-based selection of heterogeneous cell populations for the treatment of malignant and hematological diseases
10/15/1998	WO1998045328A2 Compositions and methods for the treatment and diagnosis of breast cancer
10/15/1998	WO1998045322A2 Diagnosis method and reagents
10/15/1998	WO1998045253A1 Activated iododerivatives for the treatment of cancer and aids
10/15/1998	WO1998044955A1 Recombinant antibodies specific for beta-amyloid ends, dna encoding and methods of use thereof
10/15/1998	WO1998044938A1 Modified proteins which bind extracellular matrix components

1 ... 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 ... 1259